* STRATA Skin Sciences Inc SSKN.OQ SSKN.O is expected
to show
a rise in quarterly revenue when it reports results on March
28.
* The Horsham Pennsylvania-based company is expected to
report a
8.4% increase in revenue to $9.822 million from $9.06 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for STRATA Skin
Sciences Inc
is for a loss of 5 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for STRATA Skin
Sciences Inc is $4.3, above its last closing price of $0.97.
This summary was machine generated March 24 at 20:49 GMT. All
figures in US dollars unless otherwise stated